OR WAIT null SECS
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
Recent FDA action (through May 2008) related to ceftobiprole, sugammadex, romiplostim, Gardasil, and amrubicin.
Approvable designation
Recommended for approval
Priority review
Orphan drug designation